Low- and medium-molecular-weight hydroxyethyl starches: Comparison of their effect on blood coagulation

Anesthesiology

Volumn 93, Issue 5, 2000, Pages 1231-1237

  Jamnicki, Marina ^a   Bombeli, Thomas ^b   Seifert, Burkhardt ^c   Zollinger, Andreas ^d   Camenzind, Vladimir ^a   Pasch, Thomas ^a   Spahn, Donat R ^a,e  

^a University Hospital of Psychiatry   (Switzerland)

^b University Hospital

^c UNIVERSITY OF ZURICH   (Switzerland)

^d TRIEMLI HOSPITAL   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Colloids; Hemodilution; Thrombelastograph analysis

Indexed keywords

BLOOD CLOTTING FACTOR 8; CALCIUM ION; FIBRINOGEN; HEMOGLOBIN; HETASTARCH; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING; BLOOD CLOTTING TIME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE; DOUBLE BLIND PROCEDURE; HEMATOCRIT; HUMAN; HUMAN EXPERIMENT; MALE; MOLECULAR WEIGHT; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; THROMBOELASTOGRAPHY;

EID: 0033761141     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200011000-00016     Document Type: Article

References (19)

1. Practice Guidelines for blood component therapy A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy
2. More on the changing indications for transfusion of blood and blood components during anesthesia
3. Human albumin administration in critically ill patients Systematic review of randomised controlled trials Cochrane Injuries Group Albumin Reviewers BMJ
4. Hydroxyethyl starch accentuates von Willebrand's disease
5. Hydroxyethyl starch: Safe or not?
6. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII
7. Pentastarch may cause fewer effects on coagulation than hetastarch
8. Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation
9. Determination of the molar substitution ratio of hydroxyethyl starches by gas chromatography
10. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation
11. Oncotic, hemodilutional, and hemostatic effects of isotonic saline and hydroxyethyl starch solutions in clinically normal ponies
12. Acquired von Willebrand disease: Concise review of occurrence, diagnosis, pathogenesis, and treatment
13. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation: An in vitro study
14. Hydroxyethyl starch antibodies in humans: Incidence and clinical relevance
15. Highly substituted hydroxyethyl starch (HES200/0.62) leads to type-I von Willebrand syndrome after repeated administration
16. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: Plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin
17. Consequences of acute normovolaemic haemodilution on haemostasis during major orthopaedic surgery
18. Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group
19. Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery